北大医药
(000788)
| 流通市值：38.32亿 | | | 总市值：38.32亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,231,193,296.53 | 957,309,406.16 | 502,359,685.42 | 2,060,014,642.65 |
| 营业收入 | 1,231,193,296.53 | 957,309,406.16 | 502,359,685.42 | 2,060,014,642.65 |
| 二、营业总成本 | 1,079,788,503.83 | 837,453,429.08 | 449,551,963.27 | 1,856,768,030.42 |
| 营业成本 | 898,422,808.9 | 710,055,592.22 | 382,158,273.99 | 1,507,540,914.04 |
| 税金及附加 | 6,968,199.74 | 5,161,517.29 | 2,491,717.2 | 10,904,583.93 |
| 销售费用 | 85,094,415.36 | 66,029,184.5 | 37,062,146.95 | 202,183,825.02 |
| 管理费用 | 72,871,243.87 | 45,767,951.66 | 23,406,614.27 | 109,751,555.25 |
| 研发费用 | 18,323,173.01 | 11,833,550.53 | 5,179,004.74 | 27,041,662.02 |
| 财务费用 | -1,891,337.05 | -1,394,367.12 | -745,793.88 | -654,509.84 |
| 其中:利息费用 | 1,937,103.3 | 1,320,858.96 | 1,855,384.78 | 4,168,555.1 |
| 其中:利息收入 | 3,945,999.19 | 2,791,137.86 | 3,831,511.71 | 5,025,465.72 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 6,376,117.2 | - | - | - |
| 加:投资收益 | 2,471,927.03 | - | - | -235,738.82 |
| 资产处置收益 | -45,302.3 | -45,752.14 | - | 185,840.72 |
| 资产减值损失(新) | -51,160.27 | -51,160.27 | -5,916.05 | -46,250,443.11 |
| 信用减值损失(新) | 728,036.56 | -1,387,658.8 | -933,768.69 | 11,529,003.17 |
| 其他收益 | 3,153,441.29 | 2,013,249.74 | 1,113,371.75 | 3,521,782.22 |
| 四、营业利润 | 164,037,852.21 | 120,384,655.61 | 52,981,409.16 | 171,997,056.41 |
| 加:营业外收入 | 3,680,341.96 | 1,695,301.34 | 1,654,364.32 | 1,160,586.09 |
| 减:营业外支出 | 1,062,531.12 | 56,069.96 | 54,741.02 | 804,590.68 |
| 五、利润总额 | 166,655,663.05 | 122,023,886.99 | 54,581,032.46 | 172,353,051.82 |
| 减:所得税费用 | 30,675,009.9 | 21,729,977.83 | 8,940,482.25 | 34,360,447.09 |
| 六、净利润 | 135,980,653.15 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 135,980,653.15 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 135,980,653.15 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 |
| 扣除非经常损益后的净利润 | 126,104,150.33 | 98,163,827.28 | 43,984,087.53 | 127,259,270.95 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.23 | 0.17 | 0.08 | 0.23 |
| (二)稀释每股收益 | 0.23 | 0.17 | 0.08 | 0.23 |
| 九、综合收益总额 | 135,980,653.15 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 |
| 归属于母公司股东的综合收益总额 | 135,980,653.15 | 100,293,909.16 | 45,640,550.21 | 137,992,604.73 |
| 公告日期 | 2025-10-31 | 2025-08-22 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |